According to a Feb. 28 news release from the company, the offering is expected to generate $1.12 billion. Humana will use the notes to repay a $500 million delayed draw term loan and for general corporate purposes.
The company initiated another $1.25 billion senior note offering in November 2022, and a $750 million debt offering in March 2022.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
